HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.

AbstractBACKGROUND:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect. Screening for this condition in HIV-infected patients from susceptible ethnic groups is recommended based on expert opinion. Here we determined the prevalence of G6PD deficiency and the occurrence of G6PD-related hemolytic events in a large cohort of patients.
METHODS:
We identified all HIV-infected adults who presented as new patients at a single urban HIV clinic between 02/01/2007 and 01/31/2009. Demographic and laboratory data including G6PD results were collected. In addition, outpatient and inpatient medical records of G6PD deficient patients were reviewed for episodes of hemolytic anemia.
RESULTS:
A total of 1172 patients were identified and G6PD testing was performed in 1110 (94.7%). Overall, 75 (6.8%) subjects had G6PD deficiency. Rates were higher among African Americans (68/699; 9.7%) and Hispanics (5/253; 2.0%). Only one non-Hispanic White subject had G6PD deficiency (1/153; 0.7%). At baseline, hemoglobin concentrations were similar among subjects with or without G6PD deficiency. Among patients with G6PD deficiency, 40 (53.3%) were prescribed trimethoprim-sulfamethoxazole or dapsone. During follow-up, five (6.7%) of these patients developed acute hemolytic anemia.
DISCUSSION:
These results provide strong clinical evidence for recommending G6PD testing in HIV-infected subjects from susceptible ethnic backgrounds.
AuthorsJose A Serpa, Erick Villarreal-Williams, Thomas P Giordano
JournalThe Journal of infection (J Infect) Vol. 61 Issue 5 Pg. 399-402 (Nov 2010) ISSN: 1532-2742 [Electronic] England
PMID20732351 (Publication Type: Journal Article)
CopyrightCopyright © 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Anti-Infective Agents
  • Drug Combinations
  • Sulfamethizole
  • trimethoprim sulfamethizole
  • Dapsone
  • Trimethoprim
  • Glucosephosphate Dehydrogenase
Topics
  • Adult
  • Black or African American (statistics & numerical data)
  • Aged
  • Anemia, Hemolytic (complications, epidemiology)
  • Anti-Infective Agents (therapeutic use)
  • Cohort Studies
  • Dapsone (therapeutic use)
  • Drug Combinations
  • Female
  • Glucosephosphate Dehydrogenase (blood)
  • Glucosephosphate Dehydrogenase Deficiency (blood, complications, drug therapy, epidemiology)
  • HIV Infections (complications, epidemiology)
  • Hispanic or Latino (statistics & numerical data)
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Sulfamethizole (therapeutic use)
  • Texas (epidemiology)
  • Trimethoprim (therapeutic use)
  • Urban Population
  • White People (statistics & numerical data)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: